Strength: 1,092 mg, 1,560 mg
Form: Once-6-Month IM Injection
Reference Brands: Invega Hafyera®(US)
Strength: 1.5 mg, 3 mg, 6 mg, 9 mg
Form: Extended-Release Tablets
Reference Brands: Invega®(US & EU)
Strength: 39 mg, 78 mg, 117 mg, 156 mg, 234 mg
Form: Once-Monthly IM Injection
Reference Brands: Xeplion®(EU); Invega Sustenna®(US)
Strength: 10 mg, 20 mg, 30 mg, 40 mg
Form: Oral Tablets (immediate-release)
Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®
Strength: 12.5 mg, 25 mg, 37.5 mg
Form: Tablet (Extended-Release)
Strength: 2 mg, 4 mg, 8 mg, 16 mg
Form: Oral Tablets
Reference Brands: Trilafon®(US & EU)
Strength: 15 mg
Form: Tablets
Reference Brands: Nardil®(US)
Strength: 65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
Strength: 1 mg, 2 mg, 4 mg
Reference Brands: Orap®(US & EU)
Strength: 200 mg/ml, 500 mg/ml
Reference Brands: Nootropil (EU/India), Piratropil (India)
Strength: 200 mg/mL, 500 mg/mL
Form: Oral solution / syrup
Reference Brands: Nootropil (India/EU), Lucetam(India), Myocalm®, Breinox®
Strength: 400 mg, 800 mg, 1200 mg
Form: Tablets/Capsules
Reference Brands: Nootropil (India/LATAM), Lucetam(India), Myocalm, Breinox
Stay updated on pharma trends and marketplace opportunities.